Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists discuss how first-generation antipsychotics primarily manage positive ...

June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...

First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...

A new study analyzing Medicaid databases from 2017 to 2021 has uncovered significant differences in how long-acting injectable (LAI) antipsychotic medications are prescribed to older adults across ...

—That question formed the basis of a new study from the U.K., which sought to learn more about the risk of tardive dyskinesia (TD)—a persistent, potentially irreversible movement disorder—in children ...

Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...

Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at least a month ...